Landmark UK Biobank proteomics study propels drug discovery

The research establishes the largest open-access proteogenomic dataset to date for the discovery of novel drug targets

Related Keywords

Nikolai Lenets ,Naomi Allen ,Chris Whelan ,Johnson ,Astrazeneca ,Editorial Article ,United Kingdom Biobank Pharma Proteomics Project ,Kingdom Biobank ,United Kingdom Biobank Pharma Proteomics ,United Kingdom Biobank ,Proximity Extension Assay ,United Kingdom ,Professor Naomi Allen ,Chief Scientist ,